CH555806A - Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure. - Google Patents

Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure.

Info

Publication number
CH555806A
CH555806A CH857671A CH857671A CH555806A CH 555806 A CH555806 A CH 555806A CH 857671 A CH857671 A CH 857671A CH 857671 A CH857671 A CH 857671A CH 555806 A CH555806 A CH 555806A
Authority
CH
Switzerland
Prior art keywords
derivatives
preparation
diaminobenzoic acid
diaminobenzoic
acid
Prior art date
Application number
CH857671A
Other languages
English (en)
Original Assignee
Sanwa Kagaku Kenkyusho Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co filed Critical Sanwa Kagaku Kenkyusho Co
Publication of CH555806A publication Critical patent/CH555806A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03CCHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C1/00Ingredients generally applicable to manufacture of glasses, glazes, or vitreous enamels
    • C03C1/002Use of waste materials, e.g. slags
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
CH857671A 1970-06-09 1971-06-08 Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure. CH555806A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP45049666A JPS4817267B1 (de) 1970-06-09 1970-06-09
FR7120913A FR2095112A5 (de) 1970-06-09 1971-06-09

Publications (1)

Publication Number Publication Date
CH555806A true CH555806A (de) 1974-11-15

Family

ID=26216441

Family Applications (1)

Application Number Title Priority Date Filing Date
CH857671A CH555806A (de) 1970-06-09 1971-06-08 Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure.

Country Status (9)

Country Link
US (1) US3867437A (de)
JP (1) JPS4817267B1 (de)
BE (1) BE768276A (de)
CH (1) CH555806A (de)
DE (1) DE2128381C3 (de)
FR (1) FR2095112A5 (de)
GB (1) GB1320484A (de)
NL (1) NL7107358A (de)
SE (1) SE366542B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660145B2 (ja) * 1989-02-09 1994-08-10 東洋紡績株式会社 新規置換アセトアミド化合物
US5183891A (en) * 1989-11-09 1993-02-02 Orsan Method for the preparation of substituted 1,4-dihydro-4-oxo-cinnoline-3-carboxylic acid, esters and salts thereof, and intermediates used in their preparation
AU2003258491A1 (en) * 2002-09-05 2004-03-29 Neurosearch A/S Amide derivatives and their use as chloride channel blockers
AR066505A1 (es) * 2007-05-11 2009-08-26 Bayer Schering Pharma Ag Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitogenos
WO2009129938A1 (en) * 2008-04-22 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituted phenoxybenzamides
JP2013508318A (ja) * 2009-10-21 2013-03-07 バイエル・ファルマ・アクチェンゲゼルシャフト 置換されたベンゾスルホンアミド誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413313A (en) * 1964-06-18 1968-11-26 Parke Davis & Co Anthranilic acid compounds and methods for their production

Also Published As

Publication number Publication date
SE366542B (de) 1974-04-29
DE2128381B2 (de) 1979-04-05
DE2128381A1 (de) 1971-12-16
FR2095112A5 (de) 1972-02-04
GB1320484A (en) 1973-06-13
BE768276A (fr) 1971-11-03
JPS4817267B1 (de) 1973-05-28
DE2128381C3 (de) 1979-11-29
NL7107358A (de) 1971-12-13
US3867437A (en) 1975-02-18

Similar Documents

Publication Publication Date Title
CH552595A (de) Verfahren zur herstellung von n-(1,1,1-trisubstituierten)methylazolen.
CH553780A (de) Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten.
CH551979A (de) Verfahren zur herstellung von 1,2-dihydropyrimidinen.
AT310953B (de) Verfahren zur Herstellung von neuen 8,9-Didehydro-10-alkoxyergolenderivaten
CH557349A (de) Verfahren zur herstellung von n-acylamino-pyrrolidinonderivaten.
CH555844A (de) Verfahren zur herstellung von 1-aza-5-hydroxymethyl-3, 7-dioxablicyclo-(3,3,0)-octanderivaten.
CH555806A (de) Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure.
CH556352A (de) Verfahren zur herstellung von 2-acylamino-1,3,4-thiadiazol-(thi)onen-(5).
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
CH550786A (de) Verfahren zur herstellung von 2,9-dioxatricyclo (4,3,1,0 3,7) decanonen.
CH551358A (de) Verfahren zur herstellung von 5,9-dioxodecansaeuren.
AT305963B (de) Verfahren zur Herstellung von N,O-Dialkylhydroxylaminen
CH558804A (de) Verfahren zur herstellung von triazolobenzodiazepinderivaten.
CH546243A (de) Verfahren zur herstellung von chinazolindion-derivaten.
CH558329A (de) Verfahren zur herstellung von 1-phenyl-2-aminoaethanolderivaten.
CH546730A (de) Verfahren zur herstellung von n,n'-bis-trifluormethyl-tetrafluoraethylendiamin.
CH557825A (de) Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen.
CH553807A (de) Verfahren zur herstellung von dibenzthiophendioxidderivaten.
CH502990A (de) Verfahren zur Herstellung von N-Kohlensäurederivaten von 1,2-Dicarbonyl-phenylhydrazonen
CH557371A (de) Verfahren zur herstellung von substituierten 5-hydroxyoenanthsaeurelactonen.
CH547796A (de) Verfahren zur herstellung von 1,3-dioxolanen und -dioxanen.
AT312577B (de) Verfahren zur Herstellung von Bicyclo-[3,3,0]-octen-(2)
CH557793A (de) Verfahren zur herstellung von sebacinsaeurediestern.
CH557343A (de) Verfahren zur herstellung von 1-6-disubstituierten 2,3-4, 5-dianhydro-idit-derivaten.
CH551995A (de) Verfahren zur herstellung von dihydropyrimidopyridazinderivaten.

Legal Events

Date Code Title Description
PL Patent ceased